Spero Therapeutics Inc (SPRO)
1.42
-0.01
(-0.70%)
USD |
NASDAQ |
Apr 24, 16:00
1.42
0.00 (0.00%)
After-Hours: 17:01
Spero Therapeutics Revenue (TTM): 96.74M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 96.74M |
| September 30, 2023 | 71.26M |
| June 30, 2023 | 48.96M |
| March 31, 2023 | 49.07M |
| December 31, 2022 | 48.58M |
| September 30, 2022 | 2.481M |
| June 30, 2022 | 2.107M |
| March 31, 2022 | 3.317M |
| December 31, 2021 |
| Date | Value |
|---|---|
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.258M |
| September 30, 2020 | -2.352M |
| June 30, 2020 | -1.704M |
| March 31, 2020 | -1.275M |
| December 31, 2019 | 0.831M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
-2.352M
Minimum
Sep 2020
96.74M
Maximum
Dec 2023
24.48M
Average
2.481M
Median
Sep 2022
Revenue (TTM) Benchmarks
| Retractable Technologies Inc | 43.60M |
| OptiNose Inc | 70.99M |
| scPharmaceuticals Inc | 13.59M |
| electroCore Inc | 16.03M |
| Equillium Inc | 36.08M |